|
Delayed
TEL AVIV STOCK EXCHANGE
13:02:44 19/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,043.00 ILa | -2.16% |
|
-2.16% | -4.66% |
| Market Cap | 122M 0 40.63M 35.09M 33.02M 30.01M 56.44M 3.89B 57.27M 387M 152M 1.95B 153M 149M 6.49B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 250M 0 83.37M 72.01M 67.75M 61.58M 116M 7.99B 118M 795M 311M 4B 313M 306M 13.31B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.16% | ||
| 1 week | -2.16% | ||
| Current month | -3.96% | ||
| 1 month | -4.22% | ||
| 3 months | -4.92% | ||
| 6 months | -15.68% | ||
| Current year | -4.66% |
| 1 week | 1,032 |  | 1,066 |
| 1 month | 1,032 | | 1,144 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,788 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 24/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 01/11/2018 |
| President | 80 | 28/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 25/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 15/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | -2.16% | -12.57% | -36.17% | 40.63M | |
| +1.09% | -3.61% | +29.51% | +106.75% | 101B | |
| -0.29% | -2.20% | +56.94% | +173.71% | 54.65B | |
| 0.00% | -2.03% | +2.47% | +279.08% | 23.67B | |
| -0.24% | -1.56% | -13.30% | -14.65% | 8.17B | |
| -1.70% | -2.92% | -34.52% | -23.09% | 7.53B | |
| -1.01% | -0.06% | -14.94% | -22.86% | 6.73B | |
| -4.01% | +0.14% | +8.13% | +21.98% | 6.52B | |
| +0.25% | +0.99% | -3.50% | +16.57% | 4.96B | |
| -0.60% | -2.17% | -7.29% | -6.50% | 3.67B | |
| Average | -0.87% | -0.71% | +1.09% | +49.48% | 21.73B | |
| Weighted average by Cap. | +0.21% | -2.45% | +26.23% | +122.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 107M 92.78M 87.29M 79.34M 149M 10.29B 151M 1.02B 401M 5.15B 403M 395M 17.15B | 301M 0 101M 86.8M 81.67M 74.23M 140M 9.63B 142M 958M 375M 4.82B 377M 369M 16.04B |
| Net income | 6.21M 0 2.07M 1.79M 1.68M 1.53M 2.88M 199M 2.92M 19.75M 7.74M 99.3M 7.78M 7.61M 331M | -18.07M -0 -6.03M -5.21M -4.9M -4.46M -8.38M -578M -8.51M -57.53M -22.54M -289M -22.66M -22.17M -963M |
| Net Debt | 127M 0 42.43M 36.65M 34.48M 31.34M 58.95M 4.07B 59.81M 405M 159M 2.03B 159M 156M 6.77B | 128M 0 42.74M 36.92M 34.73M 31.57M 59.38M 4.1B 60.25M 407M 160M 2.05B 160M 157M 6.82B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/08/26 | ILA 1,043.00 | -2.16% | 46 |
| 18/08/26 | ILA 1,066.00 | 0.00% | 2 |
| 17/08/26 | ILA 1,066.00 | 0.00% | 404 |
| 14/08/26 | ILA 1,066.00 | 0.00% | 1 |
| 13/08/26 | ILA 1,066.00 | 0.00% | 2 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
